Drug Description in Trials / DrugBank / KEGG DRUG
Search results
Showing 1 to 10 of 10 descriptions
| No. | 薬物名（臨床試験情報から抽出） | DrugBank | KEGG DRUG | KEGG GENES | KEGG PATHWAY | 指定難病告示番号 | |||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Dalfampridine | 1件: Dalfampridine Dalfampridine | 1件: Dalfampridine
Dalfampridine
💬1. Dalfampridine
| 4件: KCNA4 KCNA4,KCNC3, KCND2, KCND3 💬 | 4件: Cortisol synthesis and secretion Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬 4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia ... | 2件: 4 4, 13 💬
| |||||||||||||||||||||||||||||||||||||||||||||||||
| 2 | Daraprim | 1件: Pyrimethamine Pyrimethamine | 1件: Pyrimethamine
Pyrimethamine
💬2. Daraprim
| - | - | 2件: 2 2, 4 💬
| |||||||||||||||||||||||||||||||||||||||||||||||||
| 3 | Dexdor | 1件: Dexmedetomidine Dexmedetomidine | 1件: Dexmedetomidine
Dexmedetomidine
💬3. Dexdor
| 3件: ADRA2A ADRA2A,ADRA2B, ADRA2C 💬 | 2件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | 4件: 2 2, 4, 6, 70 💬
| |||||||||||||||||||||||||||||||||||||||||||||||||
| 4 | DEXMEDETOMIDINE | 1件: Dexmedetomidine Dexmedetomidine | 1件: Dexmedetomidine
Dexmedetomidine
💬4. DEXMEDETOMIDINE
| 3件: ADRA2A ADRA2A,ADRA2B, ADRA2C 💬 | 2件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | 14件: 2 2, 4, 6, 21, 34, 46, 70, 107, 113, 171, 212, 215, 226, 280 💬4. DEXMEDETOMIDINE
| |||||||||||||||||||||||||||||||||||||||||||||||||
| 5 | ESKETAMINE | 1件: Esketamine Esketamine | 1件: Esketamine
Esketamine
💬5. ESKETAMINE
| 5件: GRIN1 GRIN1,GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 5. ESKETAMINE | 20件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium si ... | 3件: 2 2, 4, 70 💬
| |||||||||||||||||||||||||||||||||||||||||||||||||
| 6 | Ketanest | - | - | - | - | 3件: 2 2, 4, 70 💬
| |||||||||||||||||||||||||||||||||||||||||||||||||
| 7 | Ketanest-S | - | - | - | - | 3件: 2 2, 4, 70 💬
| |||||||||||||||||||||||||||||||||||||||||||||||||
| 8 | Levetiracetam | 1件: Levetiracetam Levetiracetam | 1件: Levetiracetam
Levetiracetam
💬8. Levetiracetam
| 1件: SV2A SV2A 💬8. Levetiracetam
| 1件: ECM-receptor interaction ECM-receptor interaction 💬 | 5件: 2 2, 4, 6, 13, 307 💬
| |||||||||||||||||||||||||||||||||||||||||||||||||
| 9 | PYRIMETHAMINE | 1件: Pyrimethamine Pyrimethamine | 1件: Pyrimethamine
Pyrimethamine
💬9. PYRIMETHAMINE
| - | - | 4件: 2 2, 4, 19, 65 💬
| |||||||||||||||||||||||||||||||||||||||||||||||||
| 10 | Stem Cells | - | - | - | - | 5件: 2 2, 4, 46, 96, 113 💬
|